Technology Trends on Lower GI Series Market Size, Share and Global Demand

 Market Insights

Market Research Future presents a comprehensive study on the global lower GI series market, stating that the market is going to expand until the year 2023 at a CAGR of 4.6%. This global report sums up by providing the development of lower GI series market and involves driving the factors that boost the market. 

A lower GI series is referred to as lower gastrointestinal series or barium enema, which is one of the medical procedures used in the examination and diagnosis of problems related to the human colon or large intestine and rectum. This test also helps in detecting diseases and abnormalities as the symptoms of the problem generated. Due to such importance of lower GI series, many companies are on the verge of investing a significant amount in research & development to introduce more of such efficient method. This factor is taking the global lower GI series market towards positive growth in the years to come, as per the research reports stated. 

Global Lower GI Series Market: Drivers & Trends

The global lower GI series market analysis has seen prospective growth in recent days. Earlier, the diagnosis of diseases in the human colon, large intestine, and rectum was very complex and challenging to diagnose. However, with the invention of a lower GI series test has pushed the healthcare industry to the next level of advancements. Therefore, the factors such as technological advancements, growing disposable income, raising people awareness about the lower GI series test has put a potential scope for the global lower GI series market to expand exponentially and would gain more valuation during the forecast period. The increase in the number of healthcare centers, hospitals, clinics, and laboratories in main regional segments, globally have also driven the global lower GI series market.

On the other hand, the global lower GI series market is also driven majorly owing to the factors such as surging incidence of GI diseases, gastric cancer, and most prominent is changing lifestyle. With that, more factors such as developing technologies, increasing cost-effective methods, and the government’s support for research have also boosted the growth of the global lower GI series market. 

On the flip side, some factors such as the availability of alternative therapies are marked to be one of the reasons that could hamper the growth of the market during the assessment period.

Key Players

Here is the list of key players in this market:

• Eisai (US)
• Cadila Pharmaceuticals
• PeaceHealth
• Purdue Pharma L.P.
• Alfa Wassermann
• NOVADAQ
• Mount Sinai Beth Israel
• AstraZeneca
• Ironwood Pharmaceuticals Inc.    

 

Market Segmentation

This MRFR report segments the global lower GI series market into applications, types of tests, and end user.

By the mode of applications, the market has been segmented into gastroenteritis, colon polyps, tumor, strictures crohn's disease, ulcerative colitis, and others.

By the mode of types of test, the market is segmented into double-contrast test and single-contrast test.

By the mode of end users, this market is segmented into hospitals, clinics, and laboratories. 

Regional Outlook

Geographically, the global lower GI series market research study segments the global lower GI series market into the regions of America, Europe, Asia Pacific, and the Middle East & Africa. 

Among all, the reports tell that America holds a significant share in the global lower GI series market, owing to the enormous investment that is being made in research and development in the healthcare sector as well as its stable economic conditions for research and development. With this, the mounting patient base and geriatric population are also there to boost the growth of the market. 

Whereas, Europe is the second largest market after the Asia Pacific on account of increasing technological improvements. The technological enhancements will thereby, result in higher efficiency and accuracy for the diagnosis process. 

Moreover, Asia Pacific has recorded to be the fastest growing market owing to the swelling prevalence of contagious diseases in this region. India and China have now started investing in research and development of the healthcare sector, which is expected to boost the global lower GI series market in this region.

Read More @ https://www.marketresearchfuture.com/reports/lower-gi-series-market-771

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Covid19 Impact on Aromatherapy Market 2018-2023 – Global Trends, Statistics, Size, Share, Regional Analysis by Key Players, Application & Products

 Aromatherapy is an alternative form of medicine which relies on scented oils and other essential compounds for improving the well-being of individuals. It can be used in conjunction with other complementary treatments of acupuncture or massage for management of chronic diseases or other medical symptoms. The global aromatherapy market report compiled by Market Research Future (MRFR) contains drivers, trends, developments, and challenges new entrants and existing players can face in the period of 2017 to 2023.

Get Latest Free Sample PDF of COVID-19/CoronaVirus Impact Analysis of Aromatherapy Market 2020@ https://www.marketresearchfuture.com/sample_request/3241

Market Overview

As per MRFR, the global aromatherapy market analysis is poised to display a CAGR of 6.18% from 2017 to 2023 (forecast period). It can touch a value of USD 4.3 billion by 2023. Benefits of the treatment after inhalation of the aroma can induce relaxation is likely to bode well for the market. A prime example includes the diffusion of eucalyptus oil can assist in digestion of foods.

Changes in lifestyles of consumers and a large number of people opting for the complementary treatment are other major drivers of the market. Clinical trials advocating the advantages of aromatherapy for the treatment of disorders can influence the market considerably. According to Cancer.gov, 58 patients showed a decrease in depression and anxiety after completion of aromatherapy sessions. Availability of various oils at lifestyle stores and online channels can fuel the global aromatherapy market growth till 2023.

But lack of proper regulations and allergic reaction of the oil to customers are factors which can prevent market growth.

Segmentation

The global aromatherapy market is segmented by product, application, and therapeutic application.

By product, it is segmented into essential oils, carrier oils & blended oils, equipment, and others. Essential oils are further segmented into herbaceous/camphoraceous, green/vegetative, spicy, citrus, floral, and others. Ultrasonic diffuser, heat diffuser, and nebulizer diffuser are other segments subsumed within the equipment segment.

By application, it is segmented into aerial diffusion, inhalation, and tropical.

By therapeutic application, it is segmented into skin and hair care, relaxation and sleep, pain management, and others.

Regional Analysis

Asia Pacific (APAC), North America, Europe, and the Middle East & Africa (MEA) are the regions discussed with respect to the market report.

North America is estimated to be one of the profitable regions for the global aromatherapy market till 2023 due to consumers opting for the treatment in the U.S. The large population and their high expendable income levels are major growth drivers of the region.

Europe is the second-largest region with France and Italy proving to be the revenue generators. Pursuance of healthy lifestyles as well as renewed interest among the people residing in the region are prime factors driving market growth. The inclusion of essential oils by popular cosmetic brands can boost the global aromatherapy market demand.

The APAC region can display a robust CAGR during the forecast period driven by consumer demand in China and India. Rising number of accidents combined with the use of oils for treating burns and scars as natural remedies can bode well for the market. Furthermore, old traditions and rituals in addition to the large number of tourists visiting for experiences can bode well for the region.

Lastly, the MEA region can contribute to the market due to the regions of Saudi Arabia and UAE. Efforts by respective governments for promoting tourism can be a viable factor for the expansion of the global aromatherapy market in the region.

Competition Outlook

Muji, Nu Skin, Tree of Life, Neal's Yard Remedies, NOW Foods, Young Living, Air Aroma, doTERRA, and Zija International are notable industry participants of the global aromatherapy market. Launch of new products and associated stationery are being launched by players for promoting the alternative form of treatment.

Industry News

Aromafloria, the US based producer of bath and body products, has launched aromatherapy based products in its new product line of Cannafloria Essentials. It contains cannabis terpenes which gives the solutions a distinct aroma.

Read More @ https://www.marketresearchfuture.com/reports/aromatherapy-market-3241 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

A Comprehensive Study exploring High Performance Covid19 Impact on Medication Management Market| MRFR

 Market Insights

Medication management is an approach to understand the purpose of the medications and its timely administration in the correct manner. Adherence to a medication regimen is vital especially for geriatrics and patients with multiple chronic conditions. Failing to comply with a medication regimen is often cited as a paramount reason why patients are readmitted in the hospital following discharge. 

Market Research Future predicted that the global Medication Management system Market is set to reach the highest CAGR of 13.4% through the forecast period, 2018-2023.

Medication management focuses on improving medication use for the patient's condition. Interventions may include medication alignment, medication management, patient / family education about medications, and patient medication configuration simulations.

The growing geriatric population is one of the most important factors in the drug management market. Older people often have significant comorbidities that increase drug use and the risk of poor outcomes. According to a 2018 study published in Clinical Epidemiology, polypharmacy affects between 40% and 50% of older people in countries with high-income. Polypharmacy increases the risk of drug-related side effects in older people because more drugs are associated with a higher risk of harmful drug interactions. Several other factors, such as the emergence of funds in the healthcare sector and the need to reduce healthcare costs, are some of the drivers of the market.

However, the high costs of software implementation and service maintenance can hinder the market growth during the forecast period.

Regional Outlook

The United States has dominated the global drug management market. This growth can be ascribed to the rise in the elderly population and the presence of the main market players in the region.

Europe ranked second in 2017 due to the presence of developed economies such as the United Kingdom, Germany, France, and other countries in the region, which is an engine for market growth.

The Asia Pacific region is likely to see the fastest growth in 2017. Factors such as health technology sector growth, increasing market penetration in the region, and growing government support for foreign investment provide regional markets in the region. Asia Pacific.

In addition, the Middle East and Africa had the lowest share of the global drug management market due to the existence of low per capita income and poor economies, especially in the African region. The Middle East region is considered an important market for the Middle East and Africa region.

Market Segmentation

Global Medication Management Market – Segmentation

For ease of understanding, the MRFR analysis has been segmented into five key dynamics: -

By Systems : Computerized Physician Order Entry Systems, Administration Software, Clinical Decision Support Systems, Inventory Management Systems, Automated Dispensing Systems, and Assurance Systems among others. 

By Services : Point-of-Care Verification Services and Adverse Drug Effects (ADE) Surveillance Services among others. 

By Mode of Delivery : Web-based Solutions, On-premise Solutions, and Cloud-based Solutions among others.

By End-user : Hospitals and Pharmacies among others.

By Regions : North America, Europe, Asia Pacific, and the Rest-of-the-World.

 Major Players

The leading players that are supporting the functioning of the global medication management market include General Electric Company, Siemens Ltd, Medical Information Technology, QuadraMed Affinity Corporation, Allscripts Healthcare Solutions, Cerner Corporation, Mckesson Corporation, Omnicell, Inc., Carefusion Corporation, Epic Systems Corporation, and Optum Inc.

Recent Updates

• Omnicell, Inc., a leading  of medication management solutions for healthcare and pharmacy systems, has announced that Mercy, one of five US healthcare systems for Oklahoma, Arkansas, Missouri, and Kansas, will take over the management of medication in your service network through its Omnicell's automation and intelligence solutions. Omnicell works with major healthcare systems, such as Mercy, and the company launches its vision for independent pharmacies, a step-by-step plan for developing a fully automated zero-error drug management infrastructure. Based on automation, data intelligence, and specialized services, the autonomous pharmacy will allow pharmacists, nurses, physicians, and pharmacist staff to focus on patient and physician satisfaction.

Read More @ https://www.marketresearchfuture.com/reports/medication-management-market-7187 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Global Spirometry Market Outlook, Geographical Segmentation, Industry Size & Share, Analysis to 2023

  Spirometry Market Overview:

The global spirometry market is expecting to touch a valuation of USD 1,106.46 million by 2023, according to Market Research Future (MRFR).  The high prevalence of respiratory disorders is the major factor driving the market growth from 2018 to 2023 (forecast period). Rising cases of chronic obstructive pulmonary disorders (COPD), technological advances in respiratory care devices, and the expanding geriatric population are factors expected to spur market demand till 2023. As per a report by Asthma UK in 2016, nearly 1,410 people died from asthma.

Get Request Free Sampl @ https://www.marketresearchfuture.com/sample_request/6539

Government initiatives to curtail smoking habits, focus on breathing diseases, rising levels of air pollution, and adoption of spirometers at homes are factors likely to augur market growth. Awareness of reimbursement policies among the public and clinicians are projected to drive patients towards taking these tests. But high costs of spirometers can act as a deterrent against market growth.

Spirometry MarketCompetitive Dashboard:

Key players in the spirometry market include Smiths Medical Inc. (U.S.), Vitalograph (U.K.), MGC Diagnostics Corporation (U.S.), Hill-Rom Holdings, Inc. (U.S.), Schiller AG (Switzerland), COSMED srl (Italy), Midmark Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Carefusion Corporation (U.S.), Nihon Kohden Corporation (Germany), and Koninklijke Philips N.V. (The Netherlands).

Spirometry Market Segmentation:

The spirometry market can be segmented by product, technology, application, and end-user.

By product, the market is segmented into table-top spirometry, hand-held spirometry, and desktop (PC) spirometry. The table-top spirometry segment accounted for 49.9% market share in 2017, followed by hand-held (31%), and desktop (19.1%). This can be attributed to adoption of spirometers in hospitals and clinics. But the desktop segment is touted to register the highest CAGR of 10.58% during the forecast period owing to its rapid diagnosis rate and increasing use of computer-based applications.

By technology, the market covers flow measurement spirometry, volume spirometry, and peak flow meters (PFM). The flow measurement spirometry segment accounted for 50.3% share in 2017. This can be attributed to its lightweight nature and compact size. Its functionality based on the familiar table-top spirometer technology and lack of frequent calibration make it popular among clinicians. But the PFM technology can register 10.58% CAGR over the forecast period to reach USD 149.76 million by 2023.

Major applications of the spirometry market include diagnostic and treatment monitoring. The diagnostic segment is further sub-segmented into asthma, interstitial pulmonary fibrosis, and COPD. The diagnostic segment accounted for 68.93% share of the market in 2017, spurred by the prevalence of breathing diseases such as asthma. But the treatment monitoring segment can exhibit the highest CAGR during the review period to reach a valuation of USD 353 million by 2023. Its valuation in 2018 was suggested to be USD 214.12 million.

Key market end-users include hospitals & clinics, research & academic institutes, diagnostic centers, and home care. The home care segment is projected to enjoy a 9.90% CAGR to reach a valuation of USD 71.14 million by 2023 from USD 44.38 million in 2018.

Spirometry Market Regional Analysis:

The spirometry market covers the latest trends and opportunities across Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas accounted for 39.74% share in the global market in 2017, followed by Europe and APAC. This can be attributed to economies such as the U.S. which are the earliest adopters of latest technologies coupled with the large patient pool suffering from respiratory disorders. The region is likely to enjoy a 10.25% CAGR over the forecast period.

The Europe spirometry market is expected to enjoy a CAGR similar to the Americas market over the forecast period to touch a valuation of USD 322.33 million by 2023. This can be credited to rising number of asthma cases and ballooned healthcare expenditure of nations such as Germany and France.

The MEA region can experience a respectable CAGR during the review period owing to improvements of healthcare infrastructure and enhanced healthcare budgets of Kuwait, Qatar, and Dubai.

The APAC region is expected to exhibit a 10.94% CAGR over the forecast period owing to high cases of chronic diseases, awareness of respiratory devices, and increased healthcare budgets of developed nations in the region. The growing geriatric populace in China and Japan can contribute to regional market revenue till 2023.

Access Report @ https://www.marketresearchfuture.com/reports/spirometry-market-6539

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 Gallbladder treatment Market Research Report - Forecast till 2023”  – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Global Gallbladder Treatments Market – Overview

The global gallbladder treatments market is growing with a swift phase; mainly due to increase in patient population and research and development done by market players to fill the gap of market. According to world cancer research fund international, the countries with the highest gallbladder cases in the world are Chile followed by Bolivia and the Republic of Korea. Increase in incidence of gall bladder cancer, rising number of screening, increased reimbursement and insurance penetration will drag the interest of biopharmaceutical researchers for developing effective drugs for the treatment.

get free sample @ https://www.marketresearchfuture.com/sample_request/3945 

Companies are continuously engaged in merger and acquisition activities for the development of best treatment for gallbladder diseases. In this regard, Boston scientific corporation, in 2016 acquired resectr tissue resection device from Distal Access, LLC which is used for treatment of uterine polyps. the resectr device will improve and expand the urology and pelvic health business and minimally invasive solutions for gynecologic surgery by the company. Also in 2017, koninklijke philips N.V. received FDA 510(k) clearance to market its ElastQ Imaging shear wave elastography for non-invasive assessment of tissue stiffness of the liver. ElastQ Imaging enables simultaneous imaging of tissue and assessment of its stiffness, which is essential for the diagnosis of various liver conditions. Using shear wave elastography to focus sound waves to assess soft tissue stiffness. Demand of new treatment to be applied in healthcare, emerging trends in gallbladder treatment and development of minimal invasive surgical procedures drive the growth of this market.

In 2017, Becton Dickinson and company acquire Bard for $24 billion. The deal is expected to Deal immediately accretive and expected to generate high single-digit accretion to adjusted EPS in fiscal year 2019 to Becton Dickinson .B, Companies are continuously invent new products and technology to capture the maximum share of global market. Thus major players invest more in research and development activity, in order to lead the global market.

Competitive Analysis:

Boston Scientific Corporation (U.S.), Intuitive Surgical Inc. (U.S.), C. R. Bard, Inc. (U.S.), Dornier MedTech GmbH (Germany), Koninklijke Philips N.V. (the Netherlands), B. Braun Melsungen AG (Germany), Sanofi S.A.  (France) are some of the leading players at the cutting edge of the competition in the market of gallbladder treatment, globally.

Gallbladder treatment play an important role in providing relief from gallbladder disease such as biliary colic, cholecystitis, gallstones, pancreatitis, and ascending cholangitis. Gallbladder refer to the small organ below the liver in the upper right abdomen. According to the American College of Gastroenterology, Gallstones occur around 20% of Americans women before the age of 60 years, whereas women between the ages of 20 and 60 years are three times more likely to develop gallstones than men.

Global Gallbladder Treatment Market   - Regional Analysis

The market of gallbladder treatment is much higher in the Americas region owing to presence of huge population which are suffering from gallbladder disease such as biliary colic, cholecystitis, gallstones, pancreatitis, and ascending cholangitis. According to National Center for Biotechnology Information, U.S. National Library of Medicine on an average surgery costs $1582.70 more per patient than conservative management, but was found to be more effective. Thus the high effectiveness of cholecystectomy has restrained the drug market for gall bladder treatment.

Europe hold the second position in global gallbladder treatment market, owing to present of well-developed healthcare structure and awareness of healthcare. Government are more focusing on research and development to introduce new treatment for their citizen.

Asia Pacific region is consider one of the big market. Whereas country like India and china have high potential of generating business for market players owing to the fastest growing economy, additionally most of the countries of this region have common lifestyle and economic conditions. Government of developing countries within this region are more focusing towards new technology and advance treatment option, thus more research and development programs are initiated for the development of new drugs. Also countries of this region are open to adopt new technology, and best treatment option from developed countries in order to improve the quality of life for their citizen. According to Mayo clinic about 95 percent of gallbladder polyps are benign but they can be cancerous.

The Middle East and Africa are low market due to his incapability of investment. Most of the countries from this region are belong from low economy, and have very slow growth.

Report Details @ https://www.marketresearchfuture.com/reports/gallbladder-treatment-market-3945

Global Analysis on Global Neurovascular Devices Market Size, Share and Research Report by 2024

 “Global Neurovascular Devices Market Research Report: Product (Aneurysm Coiling & Embolization Devices, Support Device) Therapeutic Application (Hemorrhagic & Ischemic Strokes) End-User (Hospitals, Ambulatory Surgical Units) – Global Forecast Till 2023”

Global Market for Neurovascular Devices to Exhibit an Above-Average Growth over the Next Six Years

Neurovascular devices are increasingly being used in for treating and management of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm. As the global burden of neurovascular disorders continue to rise, the demand for their treatments gains further traction. Neurovascular disease are complex in nature and hence preference for minimally invasive procedures is higher. This, in turn, is driving the sales of neurovascular devices across the globe. Market Research Future (FRMR) is its latest report asserts that the global neurovascular devices Market will grow at a healthy rate over the next couple of years.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5544  

Incessant product innovation, increased product marketing and favourable reimbursement policies are driving the global market for neurovascular devices. Other factors that are reflecting favourably on the market include expansion of the geriatric population, and advances in medical technology in the field of interventional neurology.  Moreover, neurovascular devices are also used in treating patients suffering for ischemic stroke or haemorrhagic. It has been observed that neurovascular device assisted interventional procedures are replacing the traditional neurosurgeries. Owing the low risk of damaging surrounding tissues and minimal surgical trauma, interventional procedure are more favoured as compared to neurosurgery. At the same time, chances of infection is significantly when neurovascular device based treatment. On the other hand, inadequate number of hilly skilled neurologist, particularly in developing countries expected to have a negative impact on the growth of the market. High cost of neurovascular devices continue to limit their user base despite their increased efficiency.

Latest Industry Highlights:

• Perflow Medical, a renowned medical devices manufacturing company based in Israel, which is primarily engaged in developing novel solution for neurovascular interventions. Has recently announced that the company successfully approved a $12 Mn funding from its investors. Reportedly, the funding syndicate in included two new international investors with the existing stakeholders.
• Junkosha a US-based company has recently introduced a unique peelable heat shrink. The technology will reportedly enable access to intricate parts of the vascular system with minimal risk of damage to the surroundings.

Global Market for Neurovascular Devices – Segmental Analysis

MRFR in its report has offer comprehensive segmental analysis of the market based on therapeutic application, end-user and product. By therapeutic application, the market is bifurcated into ischemic strokes and hemorrhagic stroke. Based on end user, the market is segment into ambulatory surgical units and hospitals & clinics. By product type, the market is segmented into stenting systems, neurothrombectomy devices, cerebral balloon angioplasty, aneurysm coiling & embolization devices and support device.

Regional Overview

The Americas is expected to hold the dominant position in the global market for neurovascular devices. This is primarily attributed to the rising incidences of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm across North and South America. In addition, presence of major players and rising healthcare spending among Americans is propelling the market in the region. Improved reimbursement scenario and rapid adoption of neurovascular devices in neurological centers across the region is also proving an impetus to the market. Asia Pacific and Europe are two other regions anticipated to present significant growth opportunities for market during the forecast period.

Global Market for Neurovascular Devices – Competitive Analysis

Leading companies operating in the global market for neurovascular devices include Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Penumbra, Inc., Evasc, Neuravi, Sensome, Delaware Corporation, Gynesonics, Stryker, Johnson & Johnson Services, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Rapid Medical, W. L. Gore & Associates, Inc., Blockade Medical, LLC., OxfordEndovascular, and Secant Group, LLC. A majority of these market participants are actively focusing on expanding market presence by engaging in merger & acquisition and reaching offshore distribution agreements with third party vendors.

Read More @ https://www.marketresearchfuture.com/reports/neurovascular-devices-market-5544

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

 

2020: Dental Sterilization Market Report and Forecast till 2023

 Prevention of Infection to Drive Global Dental Sterilization Market

 

The dental industry is vast with clinics mushrooming due to the abundance of dentists and an array of instruments for surgery and diagnosis. Dental sterilization is a vital part of the routine of dentists to ensure the instruments are void of bacteria and other infections. The global dental sterilization market report by Market Research Future (MRFR) comprises drivers, challenges, trends, and opportunities for the period of 2017 to 2023 (forecast period).

Market Scope

The global dental sterilization market is set to showcase a CAGR of 6.90% over the forecast period. It can reach a value of USD 1.5 billion by 2023. It stood at USD 1.1 billion in 2017.

High prevalence of dental diseases is the primary driver of the market. For instance, dental caries is one of the common dental diseases and affects 90% of school children in the U.S. This can be credited to sugar-rich diets of consumers and lack of traditional teeth strengthening factors. Consumption of fast foods is one of the major drivers of the market. Rise in dental surgeries and technological breakthroughs in diagnosis of infectious diseases can influence market demand.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6659

Emergence of dental clinics and establishment of facilities dedicated to tooth care can fuel market growth exponentially. Rising cases of dental diseases can fuel its growth and drive the demand for dental sterilization. Efforts taken by governments for introducing practices for sterilization and prevention of cross-infection will bode fruit in the coming years. Government campaigns advocating the use of reimbursement for dental care providers can see a rise in the sales of equipment. Moreover, development of antimicrobial techniques for cleaning and disinfection can encourage sales till 2023.

Segmentation

The global dental sterilization market report is segmented by product and end use.

By product, the global dental sterilization market is segmented into instruments, consumables, and accessories. Instruments comprise cleaning and disinfectant equipment, sterilization equipment, and packaging. Similarly, accessories encompass lubrication and cleaning solutions, packaging accessories, surface disinfectants, and packaging disinfectants. Of these, the instruments segment is likely to remain the dominant contributor to the global dental sterilization market over the forecast period.

By end use, it is segmented into hospitals, dental laboratories, and others. Hospitals are likely to remain the leading segment, remaining a larger contributor to the global dental sterilization market than dental laboratories and others.

Regional Analysis

Regionally, the global dental sterilization market is segmented into North America, Europe, Asia Pacific (APAC), and Rest-of-the-World (RoW).

North America is likely to retain its status as the leader in the global dental sterilization market throughout the forecast period. The large consumer base prioritizing on oral health, awareness of individuals pertaining to healthcare, reimbursement policies covering dental procedures, and expendable income levels are major drivers of the regional market. Sterilization equipment offered to dentists and oral health experts are likely to bode well for the global dental sterilization market.

APAC can experience a strong growth rate during the assessment period owing to improving healthcare in developing economies in the region. Medical tourism and awareness of citizens of the importance of oral health can augur favorably for the regional market. Establishment of dental clinics and hospitals can trigger the demand for dental sterilization equipment.

In RoW, Latin America can witness a moderate adoption rate of products. The expendable income levels of patients, economic growth, and investment of companies in the region can fuel the global dental sterilization market demand.

Competitive Outlook

A-Dec, Scican, BMT Medical Technology, W&H, Planmeca Group, Nakanishi, Premier Dental, Matachana Group, Midmark, Hu-Friedy, Crosstex, Getinge, Tuttnaue, Dentsply Sirona, and Danaher are major players of the global dental sterilization market.

Read More @ https://www.marketresearchfuture.com/reports/dental-sterilization-market-6659